A comparative pulmonary pharmacokinetic study of budesonide using polymeric nanoparticles targeted to the lungs in treatment of asthma.

Ahmad N, Ahmad R, Almakhamel MZ, Ansari K, Amir M, Ahmad W, Ali A, Ahmad FJ

DOI: 10.1080/21691401.2020.1748640
Published: 2020 Dec
Container: Artificial cells, nanomedicine, and biotechnology
Publisher: Not recorded
Open access: unknown

Credibility signals

serious concern Score 8/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1080/21691401.2020.1748640,
  title = {A comparative pulmonary pharmacokinetic study of budesonide using polymeric nanoparticles targeted to the lungs in treatment of asthma.},
  author = {Ahmad N and Ahmad R and Almakhamel MZ and Ansari K and Amir M and Ahmad W and Ali A and Ahmad FJ},
  year = {2020},
  journal = {Artificial cells, nanomedicine, and biotechnology},
  doi = {10.1080/21691401.2020.1748640},
  url = {https://doi.org/10.1080/21691401.2020.1748640}
}

RIS

TY  - JOUR
TI  - A comparative pulmonary pharmacokinetic study of budesonide using polymeric nanoparticles targeted to the lungs in treatment of asthma.
AU  - Ahmad N
AU  - Ahmad R
AU  - Almakhamel MZ
AU  - Ansari K
AU  - Amir M
AU  - Ahmad W
AU  - Ali A
AU  - Ahmad FJ
PY  - 2020
JO  - Artificial cells, nanomedicine, and biotechnology
DO  - 10.1080/21691401.2020.1748640
UR  - https://doi.org/10.1080/21691401.2020.1748640
ER  -

APA

N, A., R, A., MZ, A., K, A., M, A., W, A., A, A., & FJ, A. (2020). A comparative pulmonary pharmacokinetic study of budesonide using polymeric nanoparticles targeted to the lungs in treatment of asthma.. Artificial cells, nanomedicine, and biotechnology. https://doi.org/10.1080/21691401.2020.1748640

Source records

pubmed · retrieved 2026-09-25T23:50:36.820Z